PHILADELPHIA, June 23, 2017 /PRNewswire/ -- FMC
Corporation (NYSE: FMC) has signed a definitive agreement to sell
its Epax® Omega-3 business to Pelagia AS. The transaction is
expected to close by the end of Q3 2017, subject to customary
regulatory approvals and closing conditions.
Logo -
http://photos.prnewswire.com/prnh/20111101/NE97440LOGO
"We are pleased to sell our Omega-3 business to Pelagia AS, a
leading manufacturer of pelagic fish products," said Eric Norris, president, FMC Health and
Nutrition. "We believe Pelagia provides a strong strategic
fit for our Epax® Omega-3 product line and will complement
Pelagia's existing portfolio."
Terms of the transaction were not disclosed.
About FMC
For more than a century, FMC Corporation has served the global
agricultural, industrial and consumer markets with innovative
solutions, applications and quality products. Revenue totaled
approximately $3.3 billion in
2016. FMC employs approximately 6,000 people throughout the
world and operates its businesses in three segments: FMC
Agricultural Solutions, FMC Health and Nutrition and FMC
Lithium. On March 31, 2017, FMC
announced the signing of a definitive agreement to acquire a
significant portion of DuPont's Crop Protection business and to
sell FMC Health and Nutrition to DuPont. Closing is expected
to occur in the fourth quarter of 2017. For more information,
visit www.FMC.com.
About Pelagia
Pelagia is the world's leading producer of pelagic fish and
marine protein and oils. Our products are sold globally with
revenue of 5.7 billion NOK /
0.7 billion USD in 100% owned
companies. Our factories are located in the United Kingdom, Ireland, Denmark and Norway and our approximately 700 employees are
processing ca 1.2 billion kilograms of pelagic fish per year.
Pelagia strives to increase value on the products we produce.
Pelagia's key strategy is being the best supplier to our
customers and being the best customer to our suppliers. We aim to
achieve this by moving our products up the value chain and the
acquisition of FMC's Epax® Omega-3 business complements this
strategy.
For more information please visit www.pelagia.com.
Safe Harbor Statement under the Private Securities Act of
1995: Statements in this news release that are forward-looking
statements are subject to various risks and uncertainties
concerning specific factors described in FMC
Corporation's 2016 Form 10-K and
other SEC filings. Such information
contained herein represents management's best judgment as of the
date hereof based on information currently
available. FMC Corporation does not intend
to update this information and disclaims any legal obligation to
the contrary. Historical information is not necessarily indicative
of future performance.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/fmc-corporation-announces-definitive-agreement-to-sell-omega-3-business-to-pelagia-as-300478908.html
SOURCE FMC Corporation